Cargando…
Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer
SIMPLE SUMMARY: With an overall 5-year survival of only 20% for advanced-stage ovarian cancer patients, enduring and effective therapies are a highly unmet clinical need. Current standard-of-care therapies are able to improve progression-free survival; however, patients still relapse. Moreover, immu...
Autores principales: | Caro, Aarushi Audhut, Deschoemaeker, Sofie, Allonsius, Lize, Coosemans, An, Laoui, Damya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406463/ https://www.ncbi.nlm.nih.gov/pubmed/36011029 http://dx.doi.org/10.3390/cancers14164037 |
Ejemplares similares
-
Systemic Reprogramming of Monocytes in Cancer
por: Kiss, Máté, et al.
Publicado: (2020) -
IFNγ signaling response in peripheral blood monocytes: A new prognostic biomarker for breast cancer?
por: Deschoemaeker, Sofie, et al.
Publicado: (2020) -
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions
por: Verheye, Emma, et al.
Publicado: (2022) -
Unleashing Tumour-Dendritic Cells to Fight Cancer by Tackling Their Three A’s: Abundance, Activation and Antigen-Delivery
por: Murgaski, Aleksandar, et al.
Publicado: (2019) -
Dendritic Cell-Based Approaches in the Fight Against Diseases
por: Freitas-Silva, Rafael, et al.
Publicado: (2014)